Grifols SA ADR [GRFS] stock is trading at $7.09, up 3.35%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The GRFS shares have gain 6.14% over the last week, with a monthly amount glided 29.62%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 4, April 2024, Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening. In a post published today on Yahoo Finance, Grifols’ in vitro nucleic acid test detects four types of arboviruses, helping mitigate the risk of transfusion-transmitted infections.
From an analyst’s perspective:
Grifols SA ADR [NASDAQ: GRFS] stock has seen the most recent analyst activity on March 12, 2024, when Deutsche Bank downgraded its rating to a Sell. Previously, Morgan Stanley upgraded its rating to Overweight on April 12, 2023. On March 03, 2023, downgrade downgraded it’s rating to Equal-Weight. Barclays upgraded its rating to a Equal Weight. Jefferies upgraded its rating to a Buy. In a note dated November 05, 2021, Deutsche Bank downgraded an Hold rating on this stock.
Grifols SA ADR [GRFS] stock has fluctuated between $5.30 and $12.15 over the past year. Grifols SA ADR [NASDAQ: GRFS] shares were valued at $7.09 at the most recent close of the market.
Analyzing the GRFS fundamentals
Grifols SA ADR [NASDAQ:GRFS] reported sales of 7.13B for the trailing twelve months, which represents a growth of 26.87%. Gross Profit Margin for this corporation currently stands at 0.37% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.04%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.02 and Total Capital is 0.04. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.8.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 6.94 points at the first support level, and at 6.79 for the second support level. However, for the 1st resistance point, the stock is sitting at 7.19, and for the 2nd resistance point, it is at 7.28.
Grifols SA ADR [GRFS] reported earnings per share of $0.15 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.24/share, meaning a difference of -$0.09 and a surprise factor of -37.50%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were $0.12 per share as compared to estimates of $0.24 per share, a difference of -$0.12 representing a surprise of -50.00%.
Ratios To Look Out For
For context, Grifols SA ADR’s Current Ratio is 2.79. As well, the Quick Ratio is 1.29, while the Cash Ratio is 0.24. Considering the valuation of this stock, the price to sales ratio is 0.26, the price to book ratio is 0.28 and price to earnings (TTM) ratio is 75.03.
